CHM Cannabis
Home > Boards > US Listed > Biotechs >

Pluristem Therapeutics, Inc. (PSTI)

Add PSTI Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 12/13/2018 10:10:51 PM - Followers: 168 - Board type: Free - Posts Today: 64


Pluristem Therapeutics Inc. (Nasdaq: PSTI) 







Company Information:

Matam Advanced Technology Park
Building #20
Haifa 31905,  Israel

Tel :  +972-74-710-7171
Fax : +972-74-710-7172
E-Mail: info@pluristem.com


CIK:  0001158780


Pluristem Therapeutics Inc. (NASDAQ: PSTI; DAX: PJT) is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases.

Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product.

The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals. 




Clinical Program: 


Recent News and Press:










Transfer Agent:

Nevada Agency and Transfer Company
50 W. Liberty St.
Suite 880
Reno, NV 89501


Investor Relations:   U.S.A.
Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North-America




All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp


CHM Cannabis
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PSTI News: Reminder- Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease Tomorrow 11:59 AM
PSTI News: Pluristem Therapeutics Enters into Cell Thawing Device License Agreement with Chart Industries, Inc. 12/04/2018 07:00:00 AM
PSTI News: Pluristem Presents Data from First Cohort in Ongoing Phase I Hematological Study at the American Society of Hematology (ASH) ... 12/03/2018 07:00:00 AM
PSTI News: The Real Impact of PAD - Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease 11/29/2018 07:30:00 AM
PSTI News: Pluristem to Present First Cohort Data from PLX-R18 Hematological Study at American Society of Hematology’s (ASH) Annual Me... 11/28/2018 08:00:00 AM
News News Alert: Reminder- Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease Tomorrow 12/13/2018 11:59:23 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#17172  Sticky Note BOARD WARNING - ALL: This board is to IH Admin [Meghan] 10/19/18 04:19:14 PM
#19205   Common Sense In This Day And Age Is FDApproved 12/13/18 10:10:51 PM
#19204   Faith is believing in something when common sense Mikems 12/13/18 09:22:44 PM
#19203   We're extremely close to a bottom. Many posts hopester 12/13/18 09:21:50 PM
#19202   Wrong. The poster asked "What debt" which prompted hopester 12/13/18 09:15:13 PM
#19201   It will be Miracle on 34th Street for Mikems 12/13/18 08:52:40 PM
#19200   "In April, Pluristem received U.S. Food and Drug PLX-11 12/13/18 07:41:47 PM
#19199   Was corrected only after someone said it nice Scott999 12/13/18 06:18:02 PM
#19198   Too many debunks to be credible. In the hopester 12/13/18 05:56:57 PM
#19197   If your post refers to mine re the hopester 12/13/18 05:53:22 PM
#19196   I corrected it. You've yet to correct anything hopester 12/13/18 05:48:33 PM
#19195   Everything they do is shrouded in secrecy and Scott999 12/13/18 05:32:24 PM
#19194   It was incredible that he didn’t know it. Scott999 12/13/18 05:29:17 PM
#19193   This is a mystery. Kronberg 12/13/18 05:17:59 PM
#19192   Deficit And Debt Are Completely Different ! Deficit FDApproved 12/13/18 04:57:19 PM
#19191   yes I saw that flash of green at thesaud 12/13/18 04:46:23 PM
#19190   Quite the day of trading huh? JonnyBeGood77 12/13/18 04:35:07 PM
#19189   Deficit, debt. All the same isn’t it? It Scott999 12/13/18 04:02:29 PM
#19188   Again your're not CREDIBLE! hopester 12/13/18 03:49:47 PM
#19187   I agree they most likely, currently, do not PLX-11 12/13/18 03:29:46 PM
#19186   PLX I don’t think we will see Kronberg 12/13/18 03:17:06 PM
#19185   Make Sure You Are Registered For 8:00 AM FDApproved 12/13/18 02:46:56 PM
#19184   Response for KOL must be huge for them Scott999 12/13/18 02:00:04 PM
#19183   Wonder if the Kakster will give the misleading Scott999 12/13/18 01:23:20 PM
#19182   Still says “not yet recruiting”. But you’re right, Scott999 12/13/18 01:15:28 PM
#19181   Not According To Clinicaltrials.gov ! It Has Not FDApproved 12/13/18 01:09:50 PM
#19180   Hip fracture has started enrollment: PLX-11 12/13/18 01:03:40 PM
#19178   Thank you Midas for your messsage.. voova99 12/13/18 12:51:22 PM
#19177   Capitulation would be 2-3million shares. Not there yet. hopester 12/13/18 12:29:33 PM
#19176   Press Release ! FDApproved 12/13/18 12:29:24 PM
#19175   I told you to E-Mail questions directly. When hopester 12/13/18 12:11:28 PM
#19174   Anyone here if Acceleron Equity Research will be Auto1 12/13/18 12:02:28 PM
#19173   Thanks Midas...Lets Hope They Can Deliver Some Very FDApproved 12/13/18 11:59:13 AM
#19172   Kaki’s Got it all under control whew. Here Scott999 12/13/18 11:58:55 AM
#19171   I send a query to PSTI in regards midastouch017 12/13/18 11:51:28 AM
#19170   Peek-A-Boo........ KOLeader.....Giddy-Up ! FDApproved 12/13/18 11:27:34 AM
#19169   Thank God for ARIAD! Auto1 12/13/18 11:08:18 AM
#19168   Day's Range 0.8100 - .8500 Auto1 12/13/18 11:05:36 AM
#19166   Tremendous progress? Full speed ahead? LMBO. Scott999 12/13/18 11:02:40 AM
#19165   The more one thinks about the 'Financial Highlight Auto1 12/13/18 11:01:06 AM
#19164   They did waste a ton of money and Scott999 12/13/18 10:52:15 AM
#19163   I think we ALL can agree, the technology Auto1 12/13/18 10:51:34 AM
#19161   yes, spot on, Scott. IMO, the biggest Auto1 12/13/18 10:40:52 AM
#19160   Seems like a tax write-off. Maybe next year Mikems 12/13/18 10:36:21 AM
#19159   waaaaahaaaahaaaawaaaahaaaa…. Says "Auto1" of "AutoEich999" zzaatt 12/13/18 10:34:51 AM
#19158   Not going to happen unfortunately. They’re going into Scott999 12/13/18 10:32:38 AM
#19157   It truly is that simple. Nobody except for Scott999 12/13/18 10:28:37 AM
#19156   ANYTHING short of an FDA approval announcement for Auto1 12/13/18 10:25:11 AM
#19155   Market Cap 97.273M... Another first... dropped below $100M. Auto1 12/13/18 10:22:22 AM
#19154   naaaah! thesaud 12/13/18 10:14:12 AM
#19153   whats really behind this selloff? Auto1 12/13/18 10:08:31 AM